Disruptive companies transforming healthcare

Healthcare delivery is hard. It is challenging even for companies where it constitutes a primary business focus. For retailers like Walmart and Walgreens, whose core competencies lie elsewhere, it proved even harder.

Technology companies must understand the flow of money and deliver better products aligned with the existing transaction models, as opposed to unwinding entrenched market participants that would otherwise have every incentive to resist change.

Real-world evidence helps provide insights into the effectiveness, safety, and value of medical interventions in real-world settings. This is possible through sophisticated analysis of real-world data to answer specific questions.

CGMs are among the most important personal medical devices. While they are prevalent today, important changes in their design, accuracy, and the scope of their measurements offer exciting opportunities for the future of data-driven health.

Two of the biggest trends in healthcare in America are Medicare Advantage and Accountable Care Organizations. Read more to learn what they are and how they will impact health delivery and costs going forward

Groundbreaking improvements in the technologies for liquid biopsies have marked a tipping point in accuracy and reliability, resulting in a significant inflection point and market opportunity.

There's an urgent need to get ahead of the massive costs that GLP-1s will add to the healthcare system, notably for payers and self-insured employes. Bedford Bridge thoughts on how virtual care providers are addressing the huge and growing market.

AI has the potential to change the role of the doctor, and diagnostics is one of the first areas where we’re seeing a dramatic change. We discuss how digital diagnostics will be impacted by AI over the coming years.